One of the key ways that tumour hypoxia leads to inflammation is through activation of the transcription factor, nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB), which leads to transcription of several pro-inflammatory factors (27). This evidence concerns the gene NFKB1 and neoplasm.